Homozygous deletion scanning of the lung cancer genome at a 100‐kb resolution
- 2 August 2007
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 46 (11) , 1000-1010
- https://doi.org/10.1002/gcc.20485
Abstract
Whole genome scanning of 43 lung cancer cell lines at a 100‐kb resolution led to identification of 51 genomic regions with homozygous deletions (HDs). The regions contained 113 genes, including two known tumor suppressor genes, RBl (RB) and CDKN2A (p16), and eight genes previously reported as being candidate tumor suppressor genes, such as PTPRD and LRP1B. Three miRNA genes, MIRNLET7C (let‐7c), MIRN99A (hsa‐mir‐99a), and MIRN125B2 (hsa‐mir‐125b‐2), were also mapped in a region with HD at 21q11‐q21. The present study provides a list of protein‐ and miRNA‐encoding genes whose inactivation is possibly involved in lung carcinogenesis.Keywords
This publication has 37 references indexed in Scilit:
- Global variation in copy number in the human genomeNature, 2006
- Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genesGenome Research, 2006
- microRNAs exhibit high frequency genomic alterations in human cancerProceedings of the National Academy of Sciences, 2006
- Common fragile sites, extremely large genes, neural development and cancerCancer Letters, 2006
- Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic FeaturesClinical Cancer Research, 2005
- Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancerGenes, Chromosomes and Cancer, 2005
- MicroRNA and Lung CancerNew England Journal of Medicine, 2005
- Detection of large-scale variation in the human genomeNature Genetics, 2004
- High-Resolution Analysis of DNA Copy Number Using Oligonucleotide MicroarraysGenome Research, 2004
- How many tumor suppressor genes are involved in human lung carcinogenesis?Carcinogenesis: Integrative Cancer Research, 1999